Atlas Trials

Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease.

Clinical trial NCT04704531 · COMPLETED

Trial details

NCT number
NCT04704531
Sponsor
Laboratorios Sophia S.A de C.V.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dry Eye
Start date
2022-01-03
Primary completion
2022-06-08
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.